The newly announced Investigator-Led Projects for Health (ILP) 2022 from the Health Research Board (HRB) will drive advancements in treatments and therapies across a broad range of human health and disease including neurodegenerative disease, respiratory disease, bloodstream infection, arthritis, cancer, and depression.